Companies / France
New Biomedical Research Taxes Unveiled
September 2006 | Legal NewsIn a move that may stifle pharmaceutical R&D and subsequently the impact country's economic health, France has introduced a series of special taxes for companies applying to the medicines regulator - Afssaps - for authorisation to carry out biomedical research. However, full charges only apply to the private sector, while public sector organistions, such as universities and hospitals will only pay 10% of the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
